Now PlayingEP. 1 Teaser: Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis
Hepatitis B Epidemiology: Closing the Screening and Diagnosis GapByRaymond Chung, MD,Douglas Dieterich, MDAugust 13th 2026
Understanding the Immune Pathophysiology Driving Chronic Hepatitis BByRaymond Chung, MD,Douglas Dieterich, MDAugust 13th 2026
Classifying Vitiligo Severity Beyond Body Surface AreaByRyan Haumschild, PharmD, MBA,David Rosmarin, MD,Seemal R. Desai, MD, FAAD,Jason Fehr, MA,Karan Lal, DO, MS, FAADAugust 12th 2026
Payer Barriers and Anatomic Urgency in Vitiligo TreatmentByRyan Haumschild, PharmD, MBA,David Rosmarin, MD,Seemal R. Desai, MD, FAAD,Jason Fehr, MA,Karan Lal, DO, MS, FAADAugust 12th 2026
From Weight Loss to Liver Normalization: A Deep Dive Into the SYNCHRONIZE-1 Trial ResultsByMazen Noureddin, MD, MHScAugust 7th 2026